128 related articles for article (PubMed ID: 15572528)
1. Antibiotics in exacerbations of COPD: lessons from the past.
Miravitlles M; Torres A
Eur Respir J; 2004 Dec; 24(6):896-7. PubMed ID: 15572528
[No Abstract] [Full Text] [Related]
2. Levofloxacin versus clarithromycin in COPD exacerbation: focus on exacerbation-free interval.
Lode H; Eller J; Linnhoff A; Ioanas M;
Eur Respir J; 2004 Dec; 24(6):947-53. PubMed ID: 15572537
[TBL] [Abstract][Full Text] [Related]
3. Bacteria in exacerbations of chronic obstructive pulmonary disease: phenomenon or epiphenomenon?
Sethi S
Proc Am Thorac Soc; 2004; 1(2):109-14. PubMed ID: 16113422
[TBL] [Abstract][Full Text] [Related]
4. [COPD and bacterial colonization: therapeutic implications].
Gómez J; Baños V; García Martín E
Rev Esp Quimioter; 2005 Jun; 18(2):187-91. PubMed ID: 16130042
[No Abstract] [Full Text] [Related]
5. [Fluoroquinolone superior to macrolide. Longer infection free period after acute bronchitis].
MMW Fortschr Med; 2003 Feb; 145(7):63. PubMed ID: 12652830
[No Abstract] [Full Text] [Related]
6. The benefits of long-term systemic antimicrobial therapy in chronic obstructive pulmonary disease.
Berim I; Sethi S
Ther Adv Respir Dis; 2011 Jun; 5(3):207-16. PubMed ID: 21378062
[TBL] [Abstract][Full Text] [Related]
7. Exacerbations of chronic obstructive pulmonary disease.
Wedzicha JA; Donaldson GC
Respir Care; 2003 Dec; 48(12):1204-13; discussion 1213-5. PubMed ID: 14651761
[TBL] [Abstract][Full Text] [Related]
8. Prudent use of antibiotics: acute exacerbation of COPD as an example.
Rohde GG
Eur Respir J; 2010 Nov; 36(5):983-5. PubMed ID: 21037365
[No Abstract] [Full Text] [Related]
9. [Respiratory fluoroquinolones in the treatment of exacerbations of chronic obstructive lung disease].
Shmelev EI
Probl Tuberk Bolezn Legk; 2004; (12):13-6. PubMed ID: 15719658
[No Abstract] [Full Text] [Related]
10. [Guidelines for the clinical management of COPD. Exacerbations/acute respiratory failure: antibiotherapy].
SPLF. Société de Pneumologie de Langue Française
Rev Mal Respir; 2003 Jun; 20(3 Pt 2):S65-8. PubMed ID: 12910099
[No Abstract] [Full Text] [Related]
11. [Routine use of extended-release clarithromycin tablets for short-course treatment of acute exacerbations of non-severe COPD].
Léophonte P; Zuck P; Perronne C; Baconnet B
Med Mal Infect; 2008 Sep; 38(9):471-6. PubMed ID: 18722065
[TBL] [Abstract][Full Text] [Related]
12. Role of Clarithromycin in Acute Exacerbations of Chronic Obstructive Pulmonary Disease.
Vora A
J Assoc Physicians India; 2017 Sep; 65(9):100-104. PubMed ID: 29313589
[TBL] [Abstract][Full Text] [Related]
13. Infection in the pathogenesis and course of chronic obstructive pulmonary disease.
Sethi S; Murphy TF
N Engl J Med; 2008 Nov; 359(22):2355-65. PubMed ID: 19038881
[No Abstract] [Full Text] [Related]
14. Clinical inquiries. Do antibiotics improve outcomes for patients hospitalized with COPD exacerbations?
Mathew S; Zeitlin D; Rickett K
J Fam Pract; 2012 Sep; 61(9):561, 573. PubMed ID: 23000666
[No Abstract] [Full Text] [Related]
15. Open-label, randomized comparison trial of long-term outcomes of levofloxacin versus standard antibiotic therapy in acute exacerbations of chronic obstructive pulmonary disease.
Ruiz-González A; Giménez A; Gómez-Arbonés X; Soler-González J; Sánchez V; Falguera M; Porcel JM
Respirology; 2007 Jan; 12(1):117-21. PubMed ID: 17207036
[TBL] [Abstract][Full Text] [Related]
16. [Clarythromycin in the treatment of exacerbations of chronic obstructive lung disease].
Shmelev EI; Ergeshev AE; Shmeleva NM; Sidorova VP
Probl Tuberk Bolezn Legk; 2006; (8):42-7. PubMed ID: 17002058
[TBL] [Abstract][Full Text] [Related]
17. Prophylactic antibiotic therapy in chronic obstructive pulmonary disease.
Maraffi T; Piffer F; Cosentini R
Ther Adv Respir Dis; 2010 Jun; 4(3):135-42. PubMed ID: 20530062
[TBL] [Abstract][Full Text] [Related]
18. Clinical predictors of bacterial involvement in exacerbations of chronic obstructive pulmonary disease.
van der Valk P; Monninkhof E; van der Palen J; Zielhuis G; van Herwaarden C; Hendrix R
Clin Infect Dis; 2004 Oct; 39(7):980-6. PubMed ID: 15472849
[TBL] [Abstract][Full Text] [Related]
19. The clinician through the looking glass: sputum microbiology in COPD exacerbations.
Bouros D; Pneumatikos I
Respiration; 2007; 74(1):13-4. PubMed ID: 16888368
[No Abstract] [Full Text] [Related]
20. Treatment of Helicobacter pylori infection: the past and the future.
Gisbert JP; Pajares JM
Eur J Intern Med; 2010 Oct; 21(5):357-9. PubMed ID: 20816583
[No Abstract] [Full Text] [Related]
[Next] [New Search]
